Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium

Overview of attention for article published in Investigational New Drugs, March 2010

Altmetric Badge

Mentioned by

So far, Dimensions has found 48 publications that cite this research output.

Article in Signal Transduction and Targeted Therapy (March 2024)

Article in Pathology - Research and Practice (May 2022)

Article in Signal Transduction and Targeted Therapy (January 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.